Breaking News Instant updates and real-time market news.

LXP

Lexington Realty

$7.93

0.155 (1.99%)

06:19
11/06/18
11/06
06:19
11/06/18
06:19

Lexington Realty raises FY18 adjusted FFO view to 93c-95c from 92c-94c

Consensus is for FY18 FFO 93c. Sees FY18 net income attributable to common shareholders per diluted common share 90c-92c.

  • 06

    Nov

LXP Lexington Realty
$7.93

0.155 (1.99%)

05/09/18
05/09/18
DOWNGRADE
Target $7

Sell
Lexington Realty downgraded to Sell on view of 'painful transition' at Stifel
As previously reported, Stifel analyst John Guinee downgraded Lexington Realty to Sell from Hold as he sees little chance of FFO growth, does not like the real estate valuation metrics and projects a "painful transition" will be required. Guinee also cites a lack of confidence in the current dividend. He lowered his price target on Lexington Realty to $7.00 from $8.50.
08/08/18
08/08/18
NO CHANGE

Lexington Realty backs FY18 adjusted FFO view 95c-98c, consensus 97c
09/27/18
WELS
09/27/18
UPGRADE
Target $9
WELS
Outperform
Lexington Realty upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Todd Stender upgraded Lexington Realty Trust to Outperform and raised his price target for the shares to $9 from $8.50. The analyst likes company's recent announcement to sell a meaningful single-tenant suburban office building portfolio into a joint venture with Davidson Kempner Capital Management. He views Lexington's strategic shift favorably though does acknowledge the earnings dilution and potential dividend cut that may result. Now the company can focus on building out a more competitive footprint within one of the most sought-after property types within the overall REIT group, Industrial/Distribution, which should lead to multiple expansion, Stender tells investors in a research note.
10/12/18
JEFF
10/12/18
UPGRADE
Target $10
JEFF
Buy
Lexington Realty upgraded to Buy from Hold at Jefferies
Jefferies analyst Jonathan Petersen upgraded Lexington Realty Trust to Buy and raised his price target for the shares to $10 from $9. While the pending dividend cut has driven yield investors "to the exits," Lexington's shift toward industrial properties and away from office can drive greater than 50% multiple expansion, Petersen tells investors in a research note. He believes this can offset the 30% earnings dilution from the shift.

TODAY'S FREE FLY STORIES

ECL

Ecolab

$163.45

1.82 (1.13%)

08:47
02/19/19
02/19
08:47
02/19/19
08:47
Earnings
Ecolab reports Q4 adj. EPS $1.54, consensus $1.54 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 13

    Mar

  • 14

    Mar

  • 20

    Mar

  • 21

    Mar

  • 22

    Mar

  • 28

    May

ORTX

Orchard Therapeutics

$15.08

0.58 (4.00%)

08:47
02/19/19
02/19
08:47
02/19/19
08:47
Conference/Events
Orchard Therapeutics management to meet with Cowen »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

GSK

GlaxoSmithKline

$41.24

0.38 (0.93%)

08:46
02/19/19
02/19
08:46
02/19/19
08:46
Conference/Events
GlaxoSmithKline management to meet with Cowen »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 18

    May

GMDA

Gamida Cell

$13.25

0.3 (2.32%)

, EDIT

Editas Medicine

$20.09

0.22 (1.11%)

08:45
02/19/19
02/19
08:45
02/19/19
08:45
Hot Stocks
Gamida Cell, Editas Medicine announce agreement to evaluate use of CRISPR tech »

Gamida Cell (GMDA)…

GMDA

Gamida Cell

$13.25

0.3 (2.32%)

EDIT

Editas Medicine

$20.09

0.22 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EXPD

Expeditors

$73.56

-0.45 (-0.61%)

08:45
02/19/19
02/19
08:45
02/19/19
08:45
Earnings
Expeditors reports Q4 EPS $1.02, consensus 85c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPO

Midstates Petroleum

$9.25

-0.17 (-1.80%)

, AXDX

Accelerate Diagnostics

$19.82

0.65 (3.39%)

08:45
02/19/19
02/19
08:45
02/19/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

MPO

Midstates Petroleum

$9.25

-0.17 (-1.80%)

AXDX

Accelerate Diagnostics

$19.82

0.65 (3.39%)

WATT

Energous

$8.91

0.11 (1.25%)

CRON

Cronos Group

$21.28

0.46 (2.21%)

NIO

NIO Inc.

$7.41

-0.07 (-0.94%)

EPD

Enterprise Products

$28.21

0.01 (0.04%)

NBEV

New Age Beverages

$6.50

-0.08 (-1.22%)

ITB

iShares U.S. Home Construction ETF

$35.22

0.36 (1.03%)

CWH

Camping World

$15.11

-0.105 (-0.69%)

SAND

Sandstorm Gold

$5.49

0.06 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 21

    Feb

  • 22

    Feb

  • 27

    Feb

  • 04

    Mar

WBC

Wabco

$116.78

0.19 (0.16%)

08:44
02/19/19
02/19
08:44
02/19/19
08:44
Recommendations
Wabco analyst commentary  »

Baird would be aggressive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADVM

Adverum Biotechnologies

$3.80

0.28 (7.95%)

08:43
02/19/19
02/19
08:43
02/19/19
08:43
Conference/Events
Adverum Biotechnologies management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 22

    Feb

  • 27

    Feb

DPZ

Domino's Pizza

$281.63

-5.46 (-1.90%)

08:43
02/19/19
02/19
08:43
02/19/19
08:43
Recommendations
Domino's Pizza analyst commentary  »

Domino's Pizza price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 14

    Mar

08:42
02/19/19
02/19
08:42
02/19/19
08:42
Conference/Events
UBS pharmaceuticals analyst to hold an analyst/industry conference call »

Pharmaceuticals Analyst…

GVA

Granite Construction

$45.48

0.59 (1.31%)

08:42
02/19/19
02/19
08:42
02/19/19
08:42
Hot Stocks
Granite's Water and Mineral Services Group awarded $22.5M in sewer projects »

Granite announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

WWW

Wolverine World Wide

$39.54

0.94 (2.44%)

08:42
02/19/19
02/19
08:42
02/19/19
08:42
Recommendations
Wolverine World Wide analyst commentary  »

Fresh Pick designation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

MCEP

Mid-Con Energy

$0.98

0.06 (6.52%)

08:41
02/19/19
02/19
08:41
02/19/19
08:41
Hot Stocks
Mid-Con Energy sell Texas properties for $60M, buys Oklahoma assets for $27.5M »

Mid-Con Energy, through…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$16.95

(0.00%)

08:41
02/19/19
02/19
08:41
02/19/19
08:41
Recommendations
Kratos Defense analyst commentary  »

Kratos Defense price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

PEP

PepsiCo

$115.89

3.4 (3.02%)

, KO

Coca-Cola

$45.25

-0.345 (-0.76%)

08:41
02/19/19
02/19
08:41
02/19/19
08:41
Upgrade
PepsiCo, Coca-Cola rating change  »

Macquarie upgrades…

PEP

PepsiCo

$115.89

3.4 (3.02%)

KO

Coca-Cola

$45.25

-0.345 (-0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 18

    May

HMST

HomeStreet

08:39
02/19/19
02/19
08:39
02/19/19
08:39
Recommendations
HomeStreet analyst commentary  »

HomeStreet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSIC

Henry Schein

$62.38

0.03 (0.05%)

08:39
02/19/19
02/19
08:39
02/19/19
08:39
Recommendations
Henry Schein analyst commentary  »

Henry Schein price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

GPC

Genuine Parts

$107.49

1.7447 (1.65%)

08:39
02/19/19
02/19
08:39
02/19/19
08:39
Hot Stocks
Breaking Hot Stocks news story on Genuine Parts »

Genuine Parts sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 04

    Apr

AEO

American Eagle

$20.07

-0.03 (-0.15%)

08:39
02/19/19
02/19
08:39
02/19/19
08:39
Hot Stocks
American Eagle announces license agreement to expand brands to Europe »

American Eagle Outfitters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

GPC

Genuine Parts

$107.49

1.7447 (1.65%)

08:37
02/19/19
02/19
08:37
02/19/19
08:37
Hot Stocks
Genuine Parts reports Q4 sales for Automotive Group up 11.4% »

Fourth quarter sales for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 04

    Apr

CHFS

CHF Solutions

$10.05

0.75 (8.06%)

08:37
02/19/19
02/19
08:37
02/19/19
08:37
Hot Stocks
CHF Solutions enters South American market with Bragenix distribution agreement »

CHF Solutions announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

MRVL

Marvell

$18.82

-0.37 (-1.93%)

08:37
02/19/19
02/19
08:37
02/19/19
08:37
Upgrade
Marvell rating change  »

Marvell upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

GPL

Great Panther Silver

$0.80

0.0576 (7.76%)

08:36
02/19/19
02/19
08:36
02/19/19
08:36
Hot Stocks
Great Panther Silver announces court approval for acquisition of Beadell »

Great Panther Silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

NUVA

NuVasive

$58.65

0.12 (0.21%)

08:36
02/19/19
02/19
08:36
02/19/19
08:36
Hot Stocks
NuVasive receives FDA 510(k) clearance for Precice Bone Transport System »

NuVasive announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

CPS

Cooper-Standard

$64.48

-9.97 (-13.39%)

08:36
02/19/19
02/19
08:36
02/19/19
08:36
Recommendations
Cooper-Standard analyst commentary  »

Cooper-Standard price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.